CD274 and cancer: In addition, after PD-L1 blockade by specific antibodies, the increased CD3+ T cell proliferation inhibition by drug-resistant cancer cells was largely reversed, while CD3+ T cell proliferation in the parental cells was only slightly changed after PD-L1 blockade, which might be due to low endogenous PD-L1 expression (Fig. 1d).